We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

2nd Symposium on Medicinal Chemistry for Global Health - Preview

2nd Symposium on Medicinal Chemistry for World Health Sunday 18 - Tuesday 20 June 2017

3 Mar 2017

Tuberculosis is one of the top ten causes of death world-wide1. High mortality rates also remain across the globe for Malaria and other diseases caused by a diverse range of pathogens, including flaviviruses (e.g. dengue, West Nile virus), kinetoplastids (e.g. Chagas disease, leishmaniasis) and parasitic worms (e.g. filariasis). However, there is an ever-improving understanding of the complex life-cycles of disease causing pathogens and this presents opportunities for those seeking to tackle these global health problems.

This June SCI, in partnership with the RSC, is returning to focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health at the 2nd Symposium on Medicinal Chemistry for Global Health. The symposium will be held from 18 - 20 June 2017, at GlaxoSmithKline, Tres Cantos, Madrid, Spain and early bird rates are available until Friday 28 April 2017 (book here).

This meeting will appeal to anyone with an interest in drug discovery and medicinal chemistry. There will be keynote talks from international experts, alongside perspectives detailing case histories in drug discovery and highlights of the latest developments in the field, whilst showcasing the opportunity for creativity and innovation.

Speakers include:

  • Dr Ann Mills Duggan, Welcome Trust, UK
     Wellcome and the challenge of diseases of the developing world
  • Prof Matthew Todd, University of Sydney, Australia
     Open source malaria drug discovery
  • Prof Chris Abell, University of Cambridge, UK
     Tackling TB targets using fragment-based strategies
  • Dr Steve Ward, Gates Foundation, USA
     Gates Foundation perspective on Cryptosporidium
  • Dr Brice Campo, Medicines for Malaria Venture, Switzerland
     MMV’s strategy and recent advances for P. vivax radical cure

This presents a fantastic opportunity for collaborative academic-industrial partnerships and open innovation discovery programmes, researchers from both sectors will benefit from the networking opportunities this meeting has to offer.

Furthermore, there is still time to submit an abstract for a poster presentation. A one-page abstract with 'Global Health - Poster Abstract'; in the subject line must be received by Friday 21 April 2017. Submit your abstract online or download an abstract template here and email it to conferences@soci.org. Selected poster presenters will also be given the opportunity to give a flash presentation.

For further information on the event and a detailed programme, please see the event page here.

Related Links

References

1WHO Tuberculosis Fact Sheet: http://www.who.int/mediacentre/factsheets/fs104/en/


Share this article